AstraZeneca Cancer Drug Sales Fuel Profit Beating Estimates

(Bloomberg) -- AstraZeneca Plc’s sales of cancer drugs surged in the most recent quarter, helping drive profit and revenue beyond analysts’ expectations.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.